Evidence map›Paper›PMID 25135638›Full record

ArticleThe Journal of biological chemistry2014

Irreversible heavy chain transfer to chondroitin.

Mark E Lauer, Vincent C Hascall, Dixy E Green, Paul L DeAngelis, Anthony Calabro

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mark E LauerFrom the Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195 and lauerm1@ccf.org.
Vincent C HascallFrom the Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195 and.
Dixy E Greenthe Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126.
Paul L DeAngelisthe Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126.
Anthony CalabroFrom the Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195 and.
Cleveland Clinic · USUniversity of Oklahoma Medical Center · US

Funding

VERSICAN PROTEOLYSIS AND REGULATION OF VASCULAR SMOOTH MUSCLEP01HL107147 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HASCALL, VINCENT CHARLES · 2011 to 2017
$16.1M
TSG-6: Novel Regulator of Viral-Induced Hyaluronan Synthesis in Inflamed AirwaysR01HL113325 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HASCALL, VINCENT CHARLES · 2013 to 2017
$1.6M
NHLBI NIH HHS 1R01HL113325-01A1NHLBI NIH HHS P01 HL107147NHLBI NIH HHS P01HL107147NHLBI NIH HHS R01 HL113325
6 · The paper itself

Abstract

We have recently demonstrated that the transfer of heavy chains (HCs) from inter-α-inhibitor, via the enzyme TSG-6 (tumor necrosis factor-stimulated gene 6), to hyaluronan (HA) oligosaccharides is an irreversible event in which subsequent swapping of HCs between HA molecules does not occur. We now describe our results of HC transfer experiments to chondroitin sulfate A, chemically desulfated chondroitin, chemoenzymatically synthesized chondroitin, unsulfated heparosan, heparan sulfate, and alginate. Of these potential HC acceptors, only chemically desulfated chondroitin and chemoenzymatically synthesized chondroitin were HC acceptors. The kinetics of HC transfer to chondroitin was similar to HA. At earlier time points, HCs were more widely distributed among the different sizes of chondroitin chains. As time progressed, the HCs migrated to lower molecular weight chains of chondroitin. Our interpretation is that TSG-6 swaps the HCs from the larger, reversible sites on chondroitin chains, which function as HC acceptors, onto smaller chondroitin chains, which function as irreversible HC acceptors. HCs transferred to smaller chondroitin chains were unable to be swapped off the smaller chondroitin chains and transferred to HA. HCs transferred to high molecular weight HA were unable to be swapped onto chondroitin. We also present data that although chondroitin was a HC acceptor, HA was the preferred acceptor when chondroitin and HA were in the same reaction mixture.

Indexed as

AlginatesAlpha-GlobulinsCell Adhesion MoleculesChondroitinChondroitin SulfatesDisaccharidesGlucuronic AcidHeparan SulfateHexuronic AcidsHumansHyaluronic AcidKineticsOligosaccharidesProtein BindingAlginatesAlpha-GlobulinsCell Adhesion MoleculesChondroitinChondroitin SulfatesDisaccharidesGlucuronic AcidHeparan SulfateheparosanHexuronic AcidsHyaluronic Acidinter-alpha-inhibitorOligosaccharidesTNFAIP6 protein, humanChondroitinChondroitin SulfateGlycosaminoglycanHeparan SulfateHyaluronan

Identifiers

PMID25135638
PMCPMC4200270
OpenAlexW1981126589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.